PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1464656
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1464656
Closed System Transfer Devices Market size was valued at USD 991.24 Million in 2023, expanding at a CAGR of 15.24% from 2024 to 2032.
Closed System Transfer Devices (CSTDs) are specialized medical equipment that have been specifically developed to ensure the safe handling of hazardous drugs during their transfer or administration. These devices are primarily used in healthcare settings, including hospitals, pharmacies, and oncology clinics. According to the National Institute for Occupational Safety and Health (NIOSH), CSTDs are designed in a way that prevents the entry of environmental contaminants into the system and the release of hazardous drugs or vapors outside of it. The implementation of these devices is of utmost importance as they play a critical role in safeguarding healthcare workers from the detrimental effects of hazardous drugs. In fact, many countries, such as the United States, have made it mandatory to use CSTDs in order to minimize the risk of exposure among healthcare professionals.
Closed System Transfer Devices Market- Market Dynamics
Increased awareness of occupational hazards is expected to propel the market growth
Regulatory bodies, such as Occupational Safety and Health Administration (OSHA) in the US and equivalent entities worldwide, have established regulations and criteria to safeguard healthcare personnel from dangerous drug exposure. Approximately 2.78 million employees perish annually due to work-related accidents and illnesses, with an additional 374 million experiencing non-fatal incidents. This results in nearly 2 million deaths from work-related issues each year, as reported by the United Nations. Additionally, advancements in technology and rising investments in healthcare infrastructure could present market growth prospects. Nevertheless, stringent regulatory demands might impede market expansion.
Closed System Transfer Devices Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 15.24% over the forecast period (2024-2032)
Based on Type segmentation, Membrane-to-Membrane Systems was predicted to show maximum market share in the year 2023
Based on Closing Mechanism segmentation, Color-To-Color Alignment Systems was the leading type in 2023
Based on Technology segmentation, Diaphragm-Based Devices was the leading type in 2023
Based on Components segmentation, Vial Access Devices was the leading type in 2023
Based on end user segmentation, Hospitals was the leading type in 2023
On the basis of region, North America was the leading revenue generator in 2023
The Global Closed System Transfer Devices Market is segmented on the basis of Type, Closing Mechanism, Technology, Components, End User, and Region.
The market is categorized into two groups according to Type: Needleless Systems and Membrane-to-Membrane Systems. Membrane-to-Membrane Systems hold the majority share in the market. They find applications in diverse industries such as water treatment, pharmaceuticals, and biotechnology. These systems utilize membranes to effectively separate components by exploiting variances in molecular size or properties.
The market is segmented into four categories according to Closing Mechanism: Color-To-Color Alignment Systems, Push-To-Turn Systems, Click-To-Lock Systems, and Luer-Lock Systems. Color-To-Color Alignment Systems are the leading category in the market. When it comes to closed system transfer devices, color-to-color alignment systems may pertain to mechanisms or characteristics that guarantee the correct alignment of components while transferring drugs.
The market is segmented into three categories according to Technology: Compartmentalized Devices, Diaphragm-Based Devices, and Air Cleaning/Filtration Devices. Diaphragm-Based Devices lead the market. These devices utilize a diaphragm or similar mechanism to establish a seal between the drug vial and the syringe or IV bag, thus preventing the release of dangerous substances during transfer.
The market is segmented into three categories according to Component: syringe Safety Devices, Vial Access Devices, Bag Access Devices, and Others. Vial Access Devices lead the market. Vial access devices are a specialized type of CSTD that offer secure access to medication vials while ensuring a closed system. These devices usually include features like vial adapters or spikes that securely attach to the medication vial, as well as a sealed pathway for transferring drugs into syringes or IV bags.
The market is segmented into two groups according to the End-User: Hospitals, Oncology Centers, and Others. Hospitals hold a dominant position in the market. These devices play a vital role in healthcare environments, particularly in hospitals, by ensuring the secure management and delivery of hazardous drugs.
Closed System Transfer Devices Market- Geographical Insights
Geographically, the market covers North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are then divided based on the countries involved in business operations. North America is anticipated to take the lead in market expansion, mainly due to the growing prevalence of chronic diseases such as cancer and the heightened emphasis on workplace safety. Cancer remains a significant contributor to mortality rates in the region, resulting in a substantial demand for oncology services, including chemotherapy. As a result, the extensive use of hazardous drugs in cancer treatment underscores the necessity of employing CSTDs to ensure safe handling and administration. According to the National Association of Chronic Diseases, nearly 60% of adult Americans are affected by at least one chronic disease. Chronic conditions like diabetes, cancer, and cardiovascular disease are the primary causes of death in the United States. Looking ahead, Europe is poised to become the second-largest region for market growth, driven by the increasing recognition of the benefits of CSTDs and the advancements in CSTD technology.
In the competitive landscape of the Closed System Transfer Devices Market, companies differentiate their CSTDs by incorporating innovative features such as advanced sealing mechanisms, integrated filtration systems, ergonomic designs, and user-friendly interfaces. Product innovation is crucial for attracting customers and outperforming competitors. Established players in this sector leverage their strong distribution networks and partnerships with healthcare facilities like hospitals, clinics, and pharmacies to maintain a competitive advantage over new entrants and smaller players. Additionally, companies focus on research and development to ensure that their CSTDs not only comply with regulatory requirements but also offer superior safety and effectiveness compared to other available products.
On December 2, 2021, B. Braun Medical Inc., a prominent supplier of closed system transfer devices (CSTD), made an announcement regarding the availability of the OnGuard 2 CSTD in the United States. The OnGuard 2 CSTD incorporates all the existing benefits of the OnGuard device, but with upgraded materials and improved features to enhance its usability.
Additionally, Baxter International Inc. (BAX) recently disclosed a distribution agreement for the introduction of the Arisure Closed System Transfer device in the United States. This platform effectively prevents contamination of the intravenous (IV) medication delivery system during drug preparation.
GLOBAL Closed System Transfer Devices MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
Becton, Dickinson and Company
Caragen Ltd
Baxter International Inc.
B. Braun Melsungen AG
ICU Medical, Inc.
Corvida Medical
JMS CO., LTD.
Equashield, LLC
Yukon Medical, LLC
Others